查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1577236

輔助人工心臟(VAD)市場至2030年的預測：按產品、設計、流量類型、應用、最終用戶和地區的全球分析

Ventricular Assist Devices Market Forecasts to 2030 - Global Analysis By Product, Design, Type of Flow, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的資料，2024年全球輔助人工心臟（VAD）市場規模將達到 36億美元，預計到2030年將達到 107億美元，預測期內年複合成長率為 19.6%。

稱為輔助人工心臟（VAD）的機械幫浦可幫助心室將血液泵送到全身並支持心臟功能。它經常被不適合接受移植手術、患有嚴重心臟衰竭或等待心臟移植的患者使用。輔助人工心臟可插入一個或兩個心室，最常見的是左心室（LVAD）、右心室（RVAD）或兩者（BiVAD）。這些可以提高患者的生活水準，增加血流量，並減輕心臟負擔。

根據美國心臟協會（AHA）的資料，預計到2030年，美國心臟衰竭的盛行率將顯著增加，患者數量將超過 800萬人。2020年，全球整體將有超過550萬人受到心臟衰竭的影響。老年人罹患心臟衰竭的風險較高。因此，人口老化的增加也在加速這種疾病的傳播。

全球心臟衰竭盛行率

在富裕國家，心臟衰竭影響 1-2%的人口。預測表明，到2030年，大約 800萬美國人可能會受到這種疾病的影響。心臟衰竭患者數量的增加是增加輔助人工心臟需求的一個主要因素。此外，老年人口中常見的慢性疾病，如糖尿病和高血壓，是心臟衰竭患者增加的主要原因，而可用心臟捐贈者的缺乏也增加了對輔助人工心臟的需求。

與移植相關的風險

出血風險增加是輔助人工心臟植入的手術後果之一，而抗凝血劑的使用可能會使情況變得更糟。控制器和電源等外部組件可能成為感染疾病的切入點，導致嚴重問題並增加移植後死亡率。血栓症是與設備相關的後果之一，需要仔細監測抗凝血治療水準，因為可能導致中風和幫浦故障。此外，心臟負荷增加引起的右心室功能障礙可能會使患者的治療結果複雜化，需要進一步治療。

輔助人工心臟技術持續創新

技術的進步導致了更堅固、更緊湊的設備的開發，提高了患者的舒適度和移動性。生物相容性的進步降低了血栓症和感染疾病的風險，減少了患者採用的障礙。由於小型化和侵入性較小，輔助人工心臟裝置已由更多患者廣泛使用，恢復時間更短，植入過程更簡單。

償付政策和保險範圍不足

輔助人工心臟不僅需要植入手術，還需要術後護理，這可能很昂貴。如果患者因保險範圍不足而必須支付大筆自付費用，他們可能不願意選擇輔助人工心臟治療。獲得醫療服務的機會不足會導致醫療干預措施的延遲或放棄、健康狀況不佳以及長期醫療費用增加，最終減少輔助人工心臟的市場需求。

COVID-19 的影響：

COVID-19 大流行對輔助人工心臟（VAD）市場產生了負面影響，導致擇期手術顯著延遲並降低了裝置利用率。由於封鎖和旅行限制，輔助人工心臟移植的數量減少，許多患者出於安全考慮而推遲了治療。結果，對輔助人工心臟的需求減少，影響了製造商和醫療保健提供者的收益。然而，隨著限制的放鬆，預計患者就診和手術將有所恢復，這可能會推動隨後的市場成長。

預計這兩個輔助人工心臟（VAD）細分市場將在預測期內成為最大的細分市場

由於 BiVAD 技術的需求增加和進步，例如可提高全輔助人工心臟心臟（TAH）植入場景中的設備性能和效用的氣動驅動系統，BiVAD 細分市場預計將在預測期內實現最高成長。 BiVAD 可以實現更好的血流動力學支援、改善生活品質、提高存活率以及提高患者和醫生的接受度。

預計橋接移植領域在預測期內年複合成長率最高。

由於在等待心臟移植期間保持患者穩定的關鍵功能，移植領域預計在預測期內將經歷最高的年複合成長率。輔助人工心臟可提供 2 至 6個月必要的機械性支持，進而改善患者的治療效果。加深對 BTT 療法有效性的了解將有助於其在心臟衰竭治療中的廣泛應用。

佔有率最大的地區

這是因為北美心臟衰竭發病率的增加和醫療設備技術的開拓共同推動了對輔助瓣膜裝置（VAD）作為到達目的地和移植的橋接治療的需求。此外，當可供移植的捐贈者心臟不足時，輔助人工心臟提供了重要的替代品，幫助患者永久生存或等待移植。

年複合成長率最高的地區：

由於中國、印度、日本和韓國對現代醫療技術和醫療保健基礎設施的投資增加，預計亞太地區在預測期內將呈現最高成長率。由於意識的提高和診斷能力的提高，對複雜心臟衰竭管理解決方案的需求不斷成長。由於技術發展，包括開發較小、更有效、問題更少的設備，亞太地區輔助人工心臟（VAD）市場不斷擴大。

提供免費客製化：

訂閱此報告的客戶可以存取以下免費自訂選項之1：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多3家公司）
    • 主要企業SWOT分析（最多3家）
  • 區域細分
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭標基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球輔助人工心臟（VAD）市場：依產品

  • LVAD
  • RVAD
  • BiVAD
  • 全人工心臟

第6章 全球輔助人工心臟（VAD）市場：設計

  • 植入式輔助人工心臟
  • 經皮輔助人工心臟（VAD）

第7章 全球輔助人工心臟（VAD）市場：依流量類型

  • 脈動流VAD
  • 連續流VAD

第8章 全球輔助人工心臟（VAD）市場：依應用分類

  • BTT（Bridge to Transplant）
  • DT（Destination Therapy）
  • BTR（Bridge to Recovery）
  • BTC（Bridge to candidacy）

第9章 全球輔助人工心臟（VAD）市場：依最終使用者分類

  • 醫院
  • 心臟外科中心
  • 居家照護機構
  • 其他最終用戶

第10章 全球輔助人工心臟（VAD）市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東、非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章 公司概況

  • Abiomed Inc.
  • BiVACOR Inc.
  • Abbott Laboratories
  • Berlin Heart GmbH
  • Calon Cardio
  • Medtronic PLC
  • SynCardia Systems LLC
  • Terumo Corporation
  • Jarvik Heart Inc.
  • ReliantHeart, Inc.
  • Sun Medical Technology Research Corp
Product Code: SMRC27556

According to Stratistics MRC, the Global Ventricular Assist Devices Market is accounted for $3.6 billion in 2024 and is expected to reach $10.7 billion by 2030 growing at a CAGR of 19.6% during the forecast period. Mechanical pumps called Ventricular Assist Devices (VADs) help the ventricles pump blood to the body, hence supporting heart function. Patients who are not candidates for transplant surgery, have significant heart failure, or are awaiting a heart transplant frequently utilize them. VADs can be inserted into one or both ventricles, the most frequent being the left ventricle (LVAD), right ventricle (RVAD), or both (BiVAD). They raise the standard of living for patients, increase blood flow, and lessen cardiac strain.

According to the American Heart Association (AHA), the prevalence of heart failure is expected to increase at a significant growth rate by 2030 in the U.S., and is projected to reach over 8 million patients. In 2020, globally, more than 5.5 million individuals were affected by heart failure. Old-age people are at high risk of HF. Therefore, the increasing geriatric population has also been fueling the disease prevalence.

Market Dynamics:

Driver:

Global prevalence of heart failure

In wealthy nations, heart failure affects 1-2% of the population; by 2030, nearly 8 million Americans may be affected, according to forecasts. The rise in heart failure instances is a major factor driving the need for VADs. Moreover chronic illnesses that are common in aging populations, such as diabetes and hypertension, are the primary cause of the rise in heart failure patients Hence the demand for VADs is increased by the scarcity of available cardiac donors.

Restraint:

Risks associated with implantation

Increased bleeding risks are one of the surgical consequences associated with VAD implants, and anticoagulant medication may make matters worse. External parts such as controllers and power supplies can act as sites of entry for infections, which can cause serious problems and higher post-transplant mortality rates. Thrombosis is one device-related consequence that requires cautious anticoagulation level monitoring because it might cause strokes or pump failure. Furthermore, right ventricular dysfunction brought on by an increased stress on the heart may complicate patient outcomes and necessitate further procedures.

Opportunity:

Continuous innovations in VAD technology

Progress in technology has resulted in more robust and compact devices, enhancing the comfort and mobility of patients. Advances in biocompatibility have lowered risks of thrombosis and infections, which has lowered obstacles to patient adoption. VAD therapy is now more widely available to a larger range of patients thanks to the less invasive nature of miniaturization, which also makes recovery times quicker and implantation processes simpler.

Threat:

Inadequate reimbursement policies and insurance coverage

VADs require implantation procedures as well as post-operative care, which can be costly. Patients may be discouraged from choosing VAD therapy if they have to pay large out-of-pocket costs due to inadequate insurance coverage. Insufficient access to care can lead to postponed or abandoned medical interventions, deteriorating health outcomes and increasing long-term healthcare expenses, ultimately decreasing market demand for VADs.

Covid-19 Impact:

The COVID-19 pandemic negatively impacted the Ventricular Assist Devices (VAD) market by causing significant delays in elective surgeries and a reduction in device utilization. Lockdowns and travel restrictions led to fewer VAD transplants, as many patients postponed seeking treatment due to safety concerns. This resulted in decreased demand for VADs, affecting revenue for manufacturers and healthcare providers. However, as restrictions eased, a rebound in patient visits and procedures is anticipated, potentially revitalizing market growth in subsequent years.

The biventricular assist devices segment is expected to be the largest during the forecast period

The biventricular assist devices segment is expected to be the largest during the forecast period owing to increased demand and advancements in BiVAD technology, such as pneumatically driven systems that improve device performance and usefulness in total artificial heart (TAH) transplant scenarios. Better hemodynamic support, improved quality of life, increased survival rates, and more patient and physician acceptance are all achieved by BiVADs.

The bridge-to-transplant segment is expected to have the highest CAGR during the forecast period

The bridge-to-transplant segment is expected to have the highest CAGR during the forecast period owing to its vital function in keeping patients stable while they await heart transplants. VADs improve patient outcomes by providing necessary mechanical support for a period of two to six months. A greater understanding of the effectiveness of BTT therapy promotes its broader use in the treatment of heart failure.

Region with largest share:

North America is expected to have the largest market share over the projection period due to the growing rate of heart failure in North America combined with technological developments in medical devices has raised demand for valve assist devices (VADs) as destination and bridge-to-transplant therapies. Moreover VADs offer a vital substitute in the event that there are insufficient donor hearts available for transplantation, assisting patients in surviving either permanently or while they wait for a transplant.

Region with highest CAGR:

Asia Pacific is anticipated to witness the highest rate of growth during the forecast period owing to increased investment in modern medical technology and healthcare infrastructure by China, India, Japan, and South Korea is contributing to the growing use of VADs. The need for sophisticated heart failure management solutions is being driven by rising awareness and enhanced diagnostic capabilities. The Asia Pacific VAD market is expanding as a result of technological developments that include the development of smaller, more effective devices with fewer issues.

Key players in the market

Some of the key players in Ventricular Assist Devices Market include Abiomed Inc., BiVACOR Inc, Abbott Laboratories, Berlin Heart GmbH, Calon Cardio, Medtronic PLC, SynCardia Systems LLC, Terumo Corporation, Jarvik Heart Inc., ReliantHeart, Inc. and Sun Medical Technology Research Corp .

Key Developments:

In September 2024, Abbott announced the findings of a new survey among leading infectious disease experts around the world on the state of pandemic preparedness and found that while most agree that preparation has improved since the COVID-19 pandemic.

In September 2024, Abbott announced U.S. availability of Lingo(TM), the company's first continuous glucose monitoring system available without a prescription. Lingo is based on Abbott's world-leading FreeStyle Libre(R) continuous glucose monitoring technology1, now used by more than 6 million people with diabetes globally.

In September 2024, Medtronic plc announced at the North American Spine Society (NASS) 39th Annual Meeting in Chicago the commercial launch of several software, hardware, and imaging innovations.

Products Covered:

  • Left Ventricular Assist Device
  • Right Ventricular Assist Device
  • Biventricular Assist Device
  • Total Artificial Heart

Designs Covered:

  • Implantable Ventricular Assist Devices
  • Transcutaneous Ventricular Assist Devices

Type of Flows Covered:

  • Pulsatile Flow VAD
  • Continuous Flow VAD

Applications Covered:

  • Bridge-to-Transplant
  • Destination Therapy
  • Bridge-to-Recovery
  • Bridge-to-Candidacy

End Users Covered:

  • Hospitals
  • Cardiac Surgery Centers
  • Home Care Agencies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Ventricular Assist Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Left Ventricular Assist Device
  • 5.3 Right Ventricular Assist Device
  • 5.4 Biventricular Assist Device
  • 5.5 Total Artificial Heart

6 Global Ventricular Assist Devices Market, By Design

  • 6.1 Introduction
  • 6.2 Implantable Ventricular Assist Devices
  • 6.3 Transcutaneous Ventricular Assist Devices

7 Global Ventricular Assist Devices Market, By Type of Flow

  • 7.1 Introduction
  • 7.2 Pulsatile Flow VAD
  • 7.3 Continuous Flow VAD

8 Global Ventricular Assist Devices Market, By Application

  • 8.1 Introduction
  • 8.2 Bridge-to-Transplant
  • 8.3 Destination Therapy
  • 8.4 Bridge-to-Recovery
  • 8.5 Bridge-to-Candidacy

9 Global Ventricular Assist Devices Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Cardiac Surgery Centers
  • 9.4 Home Care Agencies
  • 9.5 Other End Users

10 Global Ventricular Assist Devices Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abiomed Inc.
  • 12.2 BiVACOR Inc.
  • 12.3 Abbott Laboratories
  • 12.4 Berlin Heart GmbH
  • 12.5 Calon Cardio
  • 12.6 Medtronic PLC
  • 12.7 SynCardia Systems LLC
  • 12.8 Terumo Corporation
  • 12.9 Jarvik Heart Inc.
  • 12.10 ReliantHeart, Inc.
  • 12.11 Sun Medical Technology Research Corp

List of Tables

  • Table 1 Global Ventricular Assist Devices Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
  • Table 4 Global Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
  • Table 5 Global Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
  • Table 6 Global Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
  • Table 7 Global Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
  • Table 8 Global Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
  • Table 9 Global Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
  • Table 10 Global Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
  • Table 11 Global Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
  • Table 12 Global Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
  • Table 13 Global Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 14 Global Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
  • Table 15 Global Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
  • Table 16 Global Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
  • Table 17 Global Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
  • Table 18 Global Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 19 Global Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 20 Global Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
  • Table 21 Global Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
  • Table 22 Global Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 23 North America Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 24 North America Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 25 North America Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
  • Table 26 North America Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
  • Table 27 North America Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
  • Table 28 North America Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
  • Table 29 North America Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
  • Table 30 North America Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
  • Table 31 North America Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
  • Table 32 North America Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
  • Table 33 North America Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
  • Table 34 North America Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
  • Table 35 North America Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 36 North America Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
  • Table 37 North America Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
  • Table 38 North America Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
  • Table 39 North America Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
  • Table 40 North America Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 41 North America Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 42 North America Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
  • Table 43 North America Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
  • Table 44 North America Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 45 Europe Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 46 Europe Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 47 Europe Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
  • Table 48 Europe Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
  • Table 49 Europe Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
  • Table 50 Europe Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
  • Table 51 Europe Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
  • Table 52 Europe Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
  • Table 53 Europe Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
  • Table 54 Europe Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
  • Table 55 Europe Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
  • Table 56 Europe Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
  • Table 57 Europe Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 58 Europe Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
  • Table 59 Europe Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
  • Table 60 Europe Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
  • Table 61 Europe Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
  • Table 62 Europe Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 63 Europe Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 64 Europe Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
  • Table 65 Europe Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
  • Table 66 Europe Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 67 Asia Pacific Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 68 Asia Pacific Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 69 Asia Pacific Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
  • Table 70 Asia Pacific Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
  • Table 71 Asia Pacific Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
  • Table 72 Asia Pacific Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
  • Table 73 Asia Pacific Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
  • Table 74 Asia Pacific Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
  • Table 75 Asia Pacific Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
  • Table 76 Asia Pacific Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
  • Table 77 Asia Pacific Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
  • Table 78 Asia Pacific Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
  • Table 79 Asia Pacific Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 80 Asia Pacific Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
  • Table 81 Asia Pacific Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
  • Table 82 Asia Pacific Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
  • Table 83 Asia Pacific Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
  • Table 84 Asia Pacific Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 85 Asia Pacific Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 86 Asia Pacific Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
  • Table 87 Asia Pacific Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
  • Table 88 Asia Pacific Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 89 South America Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 90 South America Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 91 South America Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
  • Table 92 South America Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
  • Table 93 South America Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
  • Table 94 South America Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
  • Table 95 South America Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
  • Table 96 South America Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
  • Table 97 South America Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
  • Table 98 South America Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
  • Table 99 South America Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
  • Table 100 South America Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
  • Table 101 South America Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 102 South America Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
  • Table 103 South America Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
  • Table 104 South America Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
  • Table 105 South America Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
  • Table 106 South America Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 107 South America Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 108 South America Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
  • Table 109 South America Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
  • Table 110 South America Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 111 Middle East & Africa Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 112 Middle East & Africa Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 113 Middle East & Africa Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
  • Table 114 Middle East & Africa Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
  • Table 115 Middle East & Africa Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
  • Table 116 Middle East & Africa Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
  • Table 117 Middle East & Africa Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
  • Table 118 Middle East & Africa Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
  • Table 119 Middle East & Africa Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
  • Table 120 Middle East & Africa Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
  • Table 121 Middle East & Africa Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
  • Table 122 Middle East & Africa Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
  • Table 123 Middle East & Africa Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 124 Middle East & Africa Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
  • Table 125 Middle East & Africa Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
  • Table 126 Middle East & Africa Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
  • Table 127 Middle East & Africa Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
  • Table 128 Middle East & Africa Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 129 Middle East & Africa Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 130 Middle East & Africa Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
  • Table 131 Middle East & Africa Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
  • Table 132 Middle East & Africa Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)